FDA Inspection 1002457 — MP Biomedicals Asia Pacific Pte Ltd
The FDA completed an inspection of MP Biomedicals Asia Pacific Pte Ltd on Nov 7, 2016 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Singapore (Singapore)